GIP has been shown to decrease food intake while blunting the metabolic adaptive responses that usually occur with calorie restriction resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids
Tell us about this article on BPC-157
Staying informed and proactive about side effects helps ensure the best outcomes
What to eat during AOD 9604 and tirzepatide combination therapy Nutrition strategy becomes critical during combination therapy
From the 49 evaluable patients, DSIP produced a beneficial effect in 48 (22 alcoholics and 26 from 27 opiate addicts), with an immediate onset of action, a good and lasting suspension of the somatic symptoms and signs
I was B12 deficient among other things, had injections which did help, but was deficient in a lot of things as not digesting food properly